Longitudinal analysis of CD4+ T cells and antibody responses to common cold coronaviruses

NewsGuard 100/100 Score

Scientists have recently revealed that memory T cell responses to common cold coronaviruses stably persist for a long time. Such responses are associated with a high level of pre-existing immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The study is currently available on the bioRxiv* preprint server.

Study: Immunological memory to Common Cold Coronaviruses assessed longitudinally over a three-year period. Image Credit: Dotted Yeti/Shutterstock
Study: Immunological memory to Common Cold Coronaviruses assessed longitudinally over a three-year period. Image Credit: Dotted Yeti/Shutterstock

This news article was a review of a preliminary scientific report that had not undergone peer-review at the time of publication. Since its initial publication, the scientific report has now been peer reviewed and accepted for publication in a Scientific Journal. Links to the preliminary and peer-reviewed reports are available in the Sources section at the bottom of this article. View Sources

Background

Common cold coronaviruses are endemic viruses of alpha- and beta-coronavirus families. These viruses have widespread circulation across the globe and cause mild respiratory infections. Phylogenetically, these viruses are related to lethal coronaviruses, including SARS-CoV, SARS-CoV-2, and Middle East respiratory syndrome coronavirus (MERS-CoV).

The antibodies generated against common cold coronaviruses are widely found in humans. Regarding cellular immunity, studies have suggested that T cell responses developed against common cold coronaviruses to some extent cross-react with SARS-CoV-2. The presence of pre-existing SARS-CoV-2-specific memory T cells in SARS-CoV-2 infection-naïve individuals further justifies the observed cross-reactivity. However, the stability and durability of common cold coronavirus-specific T cell responses in the human population are uncertain.    

In the current study, the scientists have longitudinally analyzed a panel of pre-pandemic samples collected between 2016 and 2019 to determine antibody and T cell responses developed against common cold coronaviruses and other respiratory viruses (influenza virus, respiratory syncytial virus, and rhinovirus).

Memory T cell responses to common cold coronaviruses

The analysis of blood samples collected longitudinally from 32 participants revealed a robust CD4+ T cell response against common cold coronaviruses in most of the samples. The T cell response primarily corresponded with central memory and effector memory T cells. The frequency of T cell response against common cold coronaviruses was comparable to that observed against other tested viruses.

Further analysis revealed that CD4+ T cell responses developed against common cold coronaviruses and other tested viruses remain stable for a long period. The fluctuation pattern in common cold coronavirus-specific T cell response over time was lower than that observed for the influenza virus. This could be because of the higher frequency of seasonal influenza infections and annual vaccination programs.

Two markers, namely HLA-DR and CD38, were analyzed in the study to determine the recent activation of virus-specific CD4+ T cells. The findings revealed that the percentage of HLA-DR+ and CD38+ T cells against influenza virus is higher than that against common cold coronaviruses. These findings indicate that the frequency of exposure to common cold coronaviruses is relatively lower than that of the influenza virus.         

The analysis of common cold coronavirus-specific T cell response patterns in each year of sample collection revealed that the responses are not related to any recent infection or frequent yearly reinfections. 

Antibody responses to common cold coronaviruses

Plasma samples collected from participants were analyzed for common cold coronavirus-specific spike receptor-binding domain (RBD) antibodies. The findings revealed a highly stable and durable antibody response to common cold coronaviruses in all participants. The high stability of the antibody response further indicates that the participants are not frequently exposed to common cold coronaviruses during the study period.

Impact of common cold coronavirus-specific T cell response on pre-existing anti-SARS-CoV-2 immunity

Whole-genome sequencing analyses indicate a high level of sequence similarity between common cold coronaviruses and SARS-CoV-2. The analysis conducted in the current study revealed a significant association between common cold coronavirus-specific memory T cell reactivity and SARS-CoV-2-specific pre-existing memory reactivity. In contrast, there was no association between high antibody reactivity to common cold coronaviruses and high pre-existing T cell reactivity to SARS-CoV-2.

Taken together, these findings indicate that the presence of cross-reactive T cell response to SARS-CoV-2 can be predicted from a high level of common cold coronavirus-specific T cell response but not from antibody responses.

Study significance

The study demonstrates that antibody and memory T cell responses developed against common cold coronaviruses are widespread, stable, and durable. A high memory T cell response to common cold coronaviruses is associated with high pre-existing immunity against SARS-CoV-2.

This news article was a review of a preliminary scientific report that had not undergone peer-review at the time of publication. Since its initial publication, the scientific report has now been peer reviewed and accepted for publication in a Scientific Journal. Links to the preliminary and peer-reviewed reports are available in the Sources section at the bottom of this article. View Sources

Journal references:

Article Revisions

  • May 12 2023 - The preprint preliminary research paper that this article was based upon was accepted for publication in a peer-reviewed Scientific Journal. This article was edited accordingly to include a link to the final peer-reviewed paper, now shown in the sources section.
Dr. Sanchari Sinha Dutta

Written by

Dr. Sanchari Sinha Dutta

Dr. Sanchari Sinha Dutta is a science communicator who believes in spreading the power of science in every corner of the world. She has a Bachelor of Science (B.Sc.) degree and a Master's of Science (M.Sc.) in biology and human physiology. Following her Master's degree, Sanchari went on to study a Ph.D. in human physiology. She has authored more than 10 original research articles, all of which have been published in world renowned international journals.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Dutta, Sanchari Sinha Dutta. (2023, May 12). Longitudinal analysis of CD4+ T cells and antibody responses to common cold coronaviruses. News-Medical. Retrieved on April 14, 2024 from https://www.news-medical.net/news/20220304/Longitudinal-analysis-of-CD42b-T-cells-and-antibody-responses-to-common-cold-coronaviruses.aspx.

  • MLA

    Dutta, Sanchari Sinha Dutta. "Longitudinal analysis of CD4+ T cells and antibody responses to common cold coronaviruses". News-Medical. 14 April 2024. <https://www.news-medical.net/news/20220304/Longitudinal-analysis-of-CD42b-T-cells-and-antibody-responses-to-common-cold-coronaviruses.aspx>.

  • Chicago

    Dutta, Sanchari Sinha Dutta. "Longitudinal analysis of CD4+ T cells and antibody responses to common cold coronaviruses". News-Medical. https://www.news-medical.net/news/20220304/Longitudinal-analysis-of-CD42b-T-cells-and-antibody-responses-to-common-cold-coronaviruses.aspx. (accessed April 14, 2024).

  • Harvard

    Dutta, Sanchari Sinha Dutta. 2023. Longitudinal analysis of CD4+ T cells and antibody responses to common cold coronaviruses. News-Medical, viewed 14 April 2024, https://www.news-medical.net/news/20220304/Longitudinal-analysis-of-CD42b-T-cells-and-antibody-responses-to-common-cold-coronaviruses.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Antibody discovery could explain mysteries about COVID-19 and long COVID